Smartleaf Asset Management »

Celldex Therapeutics shares owned by Smartleaf Asset Management

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Smartleaf Asset Management from 13F filings

Historical chart of Smartleaf Asset Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Smartleaf Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Smartleaf Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.3k 190 33.20
2024-06-30 $1.1k 28 37.68

More positions owned by Smartleaf Asset Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Wisdomtree Tr Us Quality Grow (QGRW)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Alphabet Cap Stk Cl A (GOOGL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Smartleaf Asset Management

Top funds holding Celldex Therapeutics

BlackRock
BlackRock
Vanguard Group
Kynam Capital Management
Eventide Asset Management
Bellevue Group
T. Rowe Price Associates
State Street Corporation
Woodline Partners
T. Rowe Price Investment Management
Point72 Asset Management
Commodore Capital
Geode Capital Management
Rock Springs Capital Management
Jennison Associates

View all funds holding Celldex Therapeutics